Table 1. Classification of Different Neuromuscular Disease Modelsa.
| sensitivity (±SD) | specificity (±SD) | AUROC (±SD) | |
|---|---|---|---|
| 30 day SOD1G93A/ vs WT | |||
| 90 day SOD1G93A/ WT | 82.5 (±2.0) | 78.0 (±3.1) | 0.86 (±0.01) |
| 30 day/90 day SOD1G93A | 85.5 (±3.8) | 86.6 (±2.5) | 0.92 (±0.01) |
| 30 day female mdx/ WT | 71.3 (±3.1) | 65.7 (±2.6) | 0.76 (±0.02) |
| 90 day female mdx/ WT | 91.6 (±2.2) | 76.4 (±3.0) | 0.91 (±0.01) |
| 30 day/90 day mdx (female) | 95.6 (±1.8) | 71.6 (±3.4) | 0.92 (±0.01) |
| 30 day female mdx/ SOD1G93A | 89.9 (±1.8) | 97.1 (±2.0) | 0.97 (±0.01) |
| 90 day female mdx/ SOD1G93A | 93.5 (±2.6) | 73.3 (±1.7) | 0.89 (± 0.02) |
a
The different comparisons are shown along with the classification performance parameters from PCA-LDA. In the 30 day SOD1 vs WT analysis, there were no significant PCs identified; thus, no model was generated.